๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Holstebro
Clinical trial register · Denmark

Clinical Trials in Holstebro, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2473 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
2473
Studies in scope
all four open statuses
1402
Recruiting now
open to new participants
436
Lead sponsors
across recruiting studies
Top sites
Copenhagen 971 Aarhus 588 Odense 439 Aalborg 382 Herlev 309
Narrow the registerReset
Recruitment status
Phase
Site location
Copenhagen971 Aarhus588 Odense439 Aalborg382 Herlev309
All 128 locations
Target enrolment
to

Trials with a site in Holstebro

14 of 2473 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
PACE Versus PE for CPTSD (PACE Trial)
NCT07371156Complex Posttraumatic Stress Disorder
Sofie Folke
Not applicable
228
Aarhus, Ballerup Municipality, Birkerรธd, Copenhagen, Fredericia, Holstebro, Karup, Nรธrresundby
2026-10-01
Recruiting
Effectiveness of the NowCath Foley in Reducing Catheter-Associated UTIs and Blockages in Long-Term Indwelling Catheter Users (REDUCE)
NCT07782762Urinary Catheters, Urinary Catheterization, Catheter-Related Infections, Catheter Associated Urinary Tract Infection
Nowwell AS
Not applicable
160
Herning, Holstebro, Ikast
2026-08-10
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
Esbjerg, Holstebro, Odense
2024-04-16
Active, closed
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
NCT04688788Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis
Rigshospitalet, Denmark
Phase 3
600
Glostrup Municipality, Aalborg, Aarhus, Esbjerg, Herlev, Hillerรธd, Holstebro, Kolding
2021-04-28
Active, closed
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
NCT04608318Chronic Lymphoid Leukemia
German CLL Study Group
Phase 3
897
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2021-03-01
Recruiting
The Nasal Microbiome and Its Importance in Disease
NCT05061329Chronic Rhinosinusitis (Diagnosis), COVID-19, Anosmia
University of Aarhus
Observational
619
Holstebro
2020-12-21
Active, closed
Bone Erosions in Rheumatoid Arthritis - Characterization Evaluated by Imaging and Histology
NCT04645381Arthritis, Rheumatoid
University of Aarhus
Observational
9
Aarhus, Holstebro
2020-11-01
Recruiting
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
NCT04332822DLBCL, Diffuse Large B Cell Lymphoma
Nordic Lymphoma Group
Phase 3
300
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2020-08-19
Active, closed
Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer
NCT04114825Prostate Cancer Recurrent
RhoVac APS
Phase 2
180
Aalborg, Aarhus, Copenhagen, Herlev, Holstebro, Odense
2019-11-19
Active, closed
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
NCT04100733Non-muscle Invasive Bladder Cancer, Urinary Biomarker
Jรธrgen Bjerggaard Jensen
Not applicable
392
Holstebro, ร…rhus N, Roskilde
2019-11-01
Recruiting
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
NCT03862859Atrial Fibrillation and Flutter, Stroke, Major Bleed, End-stage Renal Disease
Nicholas Carlson
Phase 4
718
Herlev, Hillerรธd, Aalborg, Aarhus, Copenhagen, Esbjerg, Holbรฆk, Holstebro
2019-10-09
Recruiting
Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation
NCT03642509Atrial Fibrillation, Stroke
University of Aarhus
Not applicable
750
Aarhus, Odense, Aalborg, Copenhagen, Holstebro
2019-01-01
Recruiting
Danish Multicenter Scapholunate Ligament Study
NCT04348253Ligament Injury, Wrist Sprain
University of Aarhus
Not applicable
100
Aarhus, Holstebro
2018-08-01
Active, closed
Anatomic Congruent Prosthetic Knee Design
NCT03633201Knee Osteoarthritis
University of Aarhus
Not applicable
75
Holstebro
2017-07-11
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-denmark/city/holstebro

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,473 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Holstebro.

How many clinical trials are recruiting in Holstebro?

6 of the 14 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 1 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Holstebro), 14 studies
PhaseStudiesRecruitingShare
Not applicable6342.9%
Phase 34128.6%
Observational2114.3%
Phase 2107.1%
Phase 4117.1%

Most active sponsors

Lead sponsors with the most studies (Holstebro)
Lead sponsorStudiesRecruiting
University of Aarhus53
German CLL Study Group10
Jรธrgen Bjerggaard Jensen10
Nicholas Carlson11
Nordic Lymphoma Group11
Nowwell AS11
RhoVac APS10
Rigshospitalet, Denmark10
Sanofi10
Sofie Folke10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.